| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | $101,59 | +7,36% | $1,44B | $310,65K | |
TMP Tompkins Financial Corporation | $97,0700 | -3,17% | $1,44B | $75,05K | |
BRUN Boost Run Inc. Class A Common Stock | $19,0300 | -5,46% | $1,44B | $3,40M | |
TWFG TWFG, Inc. Common Stock | $27,5200 | +2,76% | $1,44B | $176,82K | |
PCT PureCycle Technologies, Inc. Common stock | $7,1600 | +4,07% | $1,44B | $4,57M | |
REX REX American Resources Corp. | $43,8700 | -0,57% | $1,43B | $127,03K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | $7,7650 | -7,01% | $1,43B | $86,36K | |
BTT BlackRock Municipal 2030 Target Term Trust | $22,8464 | +1,13% | $1,43B | $41,36K | |
ADNT Adient plc Ordinary Shares | $19,6300 | +0,77% | $1,43B | $694,96K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | $26,9900 | -0,04% | $1,43B | $1,83M | |
| $37,2100 | -0,93% | $1,43B | $1,14M | |
EMAT Evolution Metals & Technologies Corp. Common Stock | $2,8500 | -8,65% | $1,43B | $580,89K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | $16,6500 | -2,12% | $1,42B | $113,12K | |
REPL Replimune Group, Inc. | $14,8100 | -4,94% | $1,42B | $3,42M | |
HCSG Healthcare Services Group | $22,9400 | +4,56% | $1,42B | $1,06M | |
